[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Clinical Workflow Solutions Market based on by Product (Data Integration, Nurse Call Systems, Rounding Solutions, Patient Flow Management, Enterprise Reporting), End Users (Hospitals, Long-term Care, Ambulatory Care Centers) & Region– Global Forecast up to 2030

November 2023 | 92 pages | ID: C38404BB8AFFEN
IHR Insights

US$ 4,500.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Hospitals and medical facilities are currently integrating medical staff management, administrative and repetitive documentation routines, and department-wide simple access to patient administrative and clinical data. Additionally, data sharing across multimodal hospitals and their branch offices is necessary, which is driving up the need for interoperable, high-quality solutions. The need for clinical workflow systems has been significantly increased by carers' demands for patient-centered care delivery and increased clinician productivity.Many organisations in the public and private sectors have acknowledged the importance of clinical workflow management systems. Furthermore, clinical centres are launching programmes to encourage the installation and integration of clinical decision support systems and electronic health records (EHRs). This is thus expected to encourage hospitals to use these services, which will have a beneficial effect on the market for clinical workflow solutions.

Clinical workflow solutions are becoming more and more popular among healthcare companies looking for more appealing, seamless, and effective ways to enhance patient outcomes and safety. This is because these solutions make it possible for real-time health data to flow continuously, leading to more informed decisions and outcomes regarding patient care. Clinical workflow solutions are expected to become more popular in the next years because they have qualities that can improve treatment quality, coordination of care, and patient satisfaction while also reducing the likelihood of medication errors and adverse drug events.

One major barrier to the adoption of IT systems in hospitals is the lack of competent staff. The increasing number of healthcare IT efforts is making it difficult for suppliers and organisations in the healthcare industry to locate qualified employees. Both in industrialised regions like the United States and Europe as well as in developing ones, there is now a marked shortage of healthcare IT personnel. Therefore, a major obstacle to the market's expansion is the shortage of qualified professionals.

Clinical Workflow Solutions Market based on Product
  • Data Integration
  • Real-time Communication Solutions
  • Workflow Automation Solutions
  • Care Collaboration Solutions
  • Enterprise Reporting & Analytics Solutions
Clinical Workflow Solutions Market based on End user
  • Hospitals
  • Long-term care facilities
  • Ambulatory care Centers
Clinical Workflow Solutions Market based on Geography
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
In 2022, the revenue share of the data integration solutions segment was above 26.4%. The necessity for integration to contain rising costs and growing data quantities has made data integration systems the top choice among healthcare service providers. Integrated systems that let clients view the patient's information while receiving care are being aggressively adopted by hospitals and other carers. This fueled the data integration systems market's expansion in 2019. The segment has grown as a result of factors like interoperability solutions, regulatory reforms and mandates, increased use of electronic medical records, and a shift in emphasis towards value-based services.

The market for care collaboration solutions has grown significantly in the last several years, and demand is predicted to rise during the projected period. The reason for this is the heightened focus on patient-centered services. Growing patient populations worldwide also push industry participants to create more practical and efficient solutions. Care management solutions enhance patient care while saving time and money by offering efficient workflow techniques.

Hospitals held the largest market value share of clinical workflow solutions in 2022—46%—due to the growth in healthcare facilities and the related data that needs to be managed effectively and privately. Furthermore, the market expansion of the category is expected to be bolstered by supporting initiatives implemented by the governments of different countries to improve and streamline the data handling capacity in the healthcare sectors. For instance, more than 60% of hospitals have implemented EHR technology, according to data released by the Healthcare Information and Management Systems Society (HIMSS) in 2019. Moreover, the West Health Institute (WHI) stated that increased usage of interoperability technologies may lead to a significant decrease in US healthcare spending.

Additionally, it is projected that the market would rise during the analysis period due to the persistent trend towards linked hospitals and efficient management solutions. One of the main reasons for the segment's strong revenue share is the growing demand for unified important clinical communications, integrated and collaborative care delivery, and a simplified call scheduling process.

Conversely, it is anticipated that ambulatory care centres will experience the greatest expansion during the course of the analysis. The primary cause of this is an increase in out-patient hospital admissions. IT-based solution integration significantly lowers medical errors and improves communication between chemists, doctors, nurses, and patients' families in ambulatory care facilities.

North America held a 40.7% market share in 2022 as a result of a rise in hospital patient admissions and research and development efforts related to healthcare solutions, both of which increase the amount of data produced and are anticipated to drive market expansion. Additionally, more money being spent on healthcare digitalization to safeguard information sharing inside organisations is a major factor in the expansion of clinical workflow solutions in the area.

The prominent players in the global clinical workflow solutions market Hill-Rom Holdings, Inc. (US), Ascom Holding AG (Switzerland), Koninklijke Philips N.V. (Netherlands), Cerner Corporation (US), Cisco Systems, Inc. (US), Stanley Black & Decker, Inc. (US), GE Healthcare (US), Epic Systems Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Spok, Inc. (US), Vocera Communications, Inc. (US), Capsule Technologies, Inc. (US), AMETEK, Inc. (US), NextGen Healthcare (US), Azure Healthcare Limited (Australia), Getinge Group (Sweden), Change Healthcare (US), athenahealth (US), Sonitor Technologies, Inc. (Norway), and Connexall (Canada).
  • This report illustrates the most vital attributes of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Clinical Workflow Solutions Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Autologous Stem Cell and Non-Stem Cell Based Therapies Market.
1. EXECUTIVE SUMMARY


2. INDUSTRY OUTLOOK

2.1. Industry Overview
2.2. Industry Trends

3. MARKET SNAPSHOT

3.1. Market Definition
3.2. Market Outlook
  3.2.1. Porter Five Forces
3.3. Related Markets

4. MARKET CHARACTERISTICS

4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. DRO - Impact Analysis

5. PRODUCT: MARKET SIZE & ANALYSIS

5.1. Overview
5.2. Data Integration
5.3. Real-time Communication Solutions
5.4. Workflow Automation Solutions
5.5. Care Collaboration Solutions
5.6. Enterprise Reporting & Analytics Solutions
5.7. Other Applications

6. END USER: MARKET SIZE & ANALYSIS

6.1. Overview
6.2. Hospitals
6.3. Long-term care facilities
6.4. Ambulatory care Centers

7. GEOGRAPHY: MARKET SIZE & ANALYSIS

7.1. Overview
7.2. North America (U.S., Mexico, Canada)
7.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
7.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
7.5. Latin America (Brazil, Argentina)
7.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)

8. COMPETITIVE LANDSCAPE

8.1. Competitor Comparison Analysis
8.2. Market Developments
  8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
  8.2.2. Product Launches and execution

9. VENDOR PROFILES

9.1. Cerner Corporation
  9.1.1. Overview
  9.1.2. Financial Overview
  9.1.3. Product Offerings
  9.1.4. Developments
  9.1.5. Business Strategy
9.2. Allscripts Healthcare Solutions, Inc.
  9.2.1. Overview
  9.2.2. Financial Overview
  9.2.3. Product Offerings
  9.2.4. Developments
  9.2.5. Business Strategy
9.3. NXGN Management, LLC
  9.3.1. Overview
  9.3.2. Financial Overview
  9.3.3. Product Offerings
  9.3.4. Developments
  9.3.5. Business Strategy
9.4. Koninklijke Philips N.V.
  9.4.1. Overview
  9.4.2. Financial Overview
  9.4.3. Product Offerings
  9.4.4. Developments
  9.4.5. Business Strategy
9.5. McKesson Corporation
  9.5.1. Overview
  9.5.2. Financial Overview
  9.5.3. Product Offerings
  9.5.4. Developments
  9.5.5. Business Strategy
9.6. Hill-Rom Services Inc.
  9.6.1. Overview
  9.6.2. Financial Overview
  9.6.3. Product Offerings
  9.6.4. Developments
  9.6.5. Business Strategy
9.7. General Electric
  9.7.1. Overview
  9.7.2. Financial Overview
  9.7.3. Product Offerings
  9.7.4. Developments
  9.7.5. Business Strategy
9.8. Cisco
  9.8.1. Overview
  9.8.2. Financial Overview
  9.8.3. Product Offerings
  9.8.4. Developments
  9.8.5. Business Strategy
9.9. Stanly Healthcare
  9.9.1. Overview
  9.9.2. Financial Overview
  9.9.3. Product Offerings
  9.9.4. Developments
  9.9.5. Business Strategy
9.10. ASCOM
  9.10.1. Overview
  9.10.2. Financial Overview
  9.10.3. Product Offerings
  9.10.4. Developments
  9.10.5. Business Strategy

10. ANALYST OPINION


11. ANNEXURE

11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
  11.3.1. Data Collation and In-house Estimation
  11.3.2. Market Triangulation
  11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations
Tables
TABLE 1. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR DATA INTEGRATION, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR REAL-TIME COMMUNICATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR WORKFLOW AUTOMATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR CARE COLLABORATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR ENTERPRISE REPORTING & ANALYTICS SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 8. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR HOSPITALS, 2021-2030 (USD BILLION)
TABLE 9. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR LONG-TERM CARE FACILITIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 10. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR AMBULATORY CARE CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 12. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 13. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 14. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 15. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 16. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 17. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 18. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 19. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 20. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 21. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 22. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 23. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 24. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 25. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 26. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 27. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 28. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 29. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 30. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 31. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 32. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 33. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 34. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 35. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 36. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 37. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 38. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 39. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 40. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 41. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 42. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 43. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 44. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 45. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 47. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 48. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 49. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 50. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 51. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 52. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
TABLE 53. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 54. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 56. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 57. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 58. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 60. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 61. CERNER CORPORATION: FINANCIALS
TABLE 62. CERNER CORPORATION: PRODUCTS & SERVICES
TABLE 63. CERNER CORPORATION: RECENT DEVELOPMENTS
TABLE 64. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: FINANCIALS
TABLE 65. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCTS & SERVICES
TABLE 66. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: RECENT DEVELOPMENTS
TABLE 67. NXGN MANAGEMENT, LLC: FINANCIALS
TABLE 68. NXGN MANAGEMENT, LLC: PRODUCTS & SERVICES
TABLE 69. NXGN MANAGEMENT, LLC: RECENT DEVELOPMENTS
TABLE 70. KONINKLIJKE PHILIPS N.V.: FINANCIALS
TABLE 71. KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES
TABLE 72. KONINKLIJKE PHILIPS N.V.: RECENT DEVELOPMENTS
TABLE 73. MCKESSON CORPORATION: FINANCIALS
TABLE 74. MCKESSON CORPORATION: PRODUCTS & SERVICES
TABLE 75. MCKESSON CORPORATION: RECENT DEVELOPMENTS
TABLE 76. HILL-ROM SERVICES INC.: FINANCIALS
TABLE 77. HILL-ROM SERVICES INC.: PRODUCTS & SERVICES
TABLE 78. HILL-ROM SERVICES INC.: RECENT DEVELOPMENTS
TABLE 79. GENERAL ELECTRIC: FINANCIALS
TABLE 80. GENERAL ELECTRIC: PRODUCTS & SERVICES
TABLE 81. GENERAL ELECTRIC: DEVELOPMENTS
TABLE 82. CISCO: FINANCIALS
TABLE 83. CISCO: PRODUCTS & SERVICES
TABLE 84. CISCO: RECENT DEVELOPMENTS
TABLE 85. STANLY HEALTHCARE: FINANCIALS
TABLE 86. STANLY HEALTHCARE: PRODUCTS & SERVICES
TABLE 87. STANLY HEALTHCARE: RECENT DEVELOPMENTS
TABLE 88. ASCOM: FINANCIALS
TABLE 89. ASCOM: PRODUCTS & SERVICES
TABLE 90. ASCOM: RECENT DEVELOPMENTS
Charts
CHART. 1. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 2. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR DATA INTEGRATION, BY GEOGRAPHY , 2021-2030 (USD BILLION)
CHART. 3. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR REAL-TIME COMMUNICATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 4. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR WORKFLOW AUTOMATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 5. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR CARE COLLABORATION SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 6. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR ENTERPRISE REPORTING & ANALYTICS SOLUTIONS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 7. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 8. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR HOSPITALS, 2021-2030 (USD BILLION)
CHART. 9. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR LONG-TERM CARE FACILITIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 10. CLINICAL WORKFLOW SOLUTIONS MARKET VALUE FOR AMBULATORY CARE CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 11. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 12. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 13. NORTH AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 14. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 15. U.S CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 16. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 17. CANADA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 18. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 19. MEXICO CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 20. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 21. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 22. EUROPE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 23. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 24. GERMANY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 25. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 26. U.K CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 27. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 28. FRANCE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 29. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 30. ITALY CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 31. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 32. SPAIN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 33. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 34. ROE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 35. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 36. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 37. ASIA PACIFIC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 38. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 39. CHINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 40. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 41. INDIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 42. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 43. JAPAN CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 44. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 45. REST OF APAC CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 46. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 47. LATIN AMERICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 48. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 49. BRAZIL CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 50. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 51. ARGENTINA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 52. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY TYPE, 2021-2030 (USD BILLION)
CHART. 53. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 54. MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 55. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 56. SAUDI ARABIA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 57. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 58. UAE CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 59. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 60. REST OF MIDDLE EAST AND AFRICA CLINICAL WORKFLOW SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 61. CERNER CORPORATION: FINANCIALS
CHART. 62. CERNER CORPORATION: PRODUCTS & SERVICES
CHART. 63. CERNER CORPORATION: RECENT DEVELOPMENTS
CHART. 64. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: FINANCIALS
CHART. 65. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: PRODUCTS & SERVICES
CHART. 66. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: RECENT DEVELOPMENTS
CHART. 67. NXGN MANAGEMENT, LLC: FINANCIALS
CHART. 68. NXGN MANAGEMENT, LLC: PRODUCTS & SERVICES
CHART. 69. NXGN MANAGEMENT, LLC: RECENT DEVELOPMENTS
CHART. 70. KONINKLIJKE PHILIPS N.V.: FINANCIALS
CHART. 71. KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES
CHART. 72. KONINKLIJKE PHILIPS N.V.: RECENT DEVELOPMENTS
CHART. 73. MCKESSON CORPORATION: FINANCIALS
CHART. 74. MCKESSON CORPORATION: PRODUCTS & SERVICES
CHART. 75. MCKESSON CORPORATION: RECENT DEVELOPMENTS
CHART. 76. HILL-ROM SERVICES INC.: FINANCIALS
CHART. 77. HILL-ROM SERVICES INC.: PRODUCTS & SERVICES
CHART. 78. HILL-ROM SERVICES INC.: RECENT DEVELOPMENTS
CHART. 79. GENERAL ELECTRIC: FINANCIALS
CHART. 80. GENERAL ELECTRIC: PRODUCTS & SERVICES
CHART. 81. GENERAL ELECTRIC: DEVELOPMENTS
CHART. 82. CISCO: FINANCIALS
CHART. 83. CISCO: PRODUCTS & SERVICES
CHART. 84. CISCO: RECENT DEVELOPMENTS
CHART. 85. STANLY HEALTHCARE: FINANCIALS
CHART. 86. STANLY HEALTHCARE: PRODUCTS & SERVICES
CHART. 87. STANLY HEALTHCARE: RECENT DEVELOPMENTS
CHART. 88. ASCOM: FINANCIALS
CHART. 89. ASCOM: PRODUCTS & SERVICES
CHART. 90. ASCOM: RECENT DEVELOPMENTS


More Publications